To find out about what Rarecells is doing around the globe explore our featured news or contact our team at newsroom@rarecells.com.
NEW YORK and PARIS, Dec. 9, 2021 — Rarecells, Inc., an innovative Liquid Biopsy company developing non-invasive tests for early cancer diagnosis, announced today the closing of a $5 Million
NEW YORK and PARIS, Dec. 9, 2021 — Rarecells, Inc., an innovative Liquid Biopsy
New York, November 9th, 2021 — Rarecells, Inc., a healthcare company in the field
We are delighted to join the prestigious The Oncology Think Tank, initiated by Prof. Azra
PARIS, April 6, 2021 /PRNewswire/ — Rarecells Inc., a leading Liquid Biopsy company is pleased to
We are enthusiastic to share the results of the Professor Karin Ried and researchers of
Attend the Keynote presentation ”New non-invasive approaches for early diagnosis and follow up of
We are enthusiastic to share the results of the research conducted by Dr Tamminga
[OPPORTUNITY] – Rarecells is looking to hire a Research Lab Director! 🧬🦠🔬 For more
Attend the Keynote presentation ” Clinical Applications of Circulating Tumor Cells in Predictive Oncology
Paris, France
Please enter the requested information below and click SEND
Please enter the requested information below and click SEND
Please enter the requested information below and click SEND